Should I buy Marsh McLennan (MRSH) stock or is it too late?

Marsh McLennan · Financials · price $177

See the full Marsh McLennan (MRSH) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Citigroup — 69% of its targets hit on this sector (647 calls tested). It aims for $200 (+13 %), call made on July 23, 2026, maturing on July 23, 2027 (83 d ago).

The 5 reliable analysts $200+13 %

The 5 other firms $203+15 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $200 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

In short — Should you invest in Marsh McLennan? Is it too late, still worth it? Analysts are split (40% buy, median target $202, i.e. +14%), and the most reliable on MRSH targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $202, i.e. +14% from the current price ($177).
The most reliable firm on MRSH, UBS (0% hit rate, 2 scored calls), targets $222 (call made on October 6, 2026, maturing on October 6, 2027) (+25%) in its most recent call, and $203 (call made on June 9, 2026, maturing on June 9, 2027) (+15%) in the one coming due soonest.
Pays a dividend (2.1% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 10 ratings, 6 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on MRSH

Median target $202 (+14%) · 10 ratings · Hold consensus

Strong Buy00%

Buy440%

Hold660%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Marsh McLennan now?

We won't decide for you. The facts: 40% of analysts rate it a buy, median target $202 (+14%), and UBS (most reliable on MRSH, 0%) targets $222. Weigh that against valuation (P/E ~22). This is not personalized advice.

Is it too late to invest in Marsh McLennan?

Not according to analysts: the median target ($202) is still +14% above the current price ($177) (most reliable on MRSH: UBS, 0%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Marsh McLennan still worth investing in?

It depends on the gap between the price ($177) and its estimated value: analysts target $202 on median (+14%), with 40% buys (most reliable on MRSH: UBS, 0%). Cross-check with their real reliability on MRSH and the cautions above. Information, not advice.

What's the main risk in buying MRSH?

The consensus is not unanimous: of 10 ratings, 6 are neutral.

→ Go deeper: the full Marsh McLennan profile (consensus, analyst reliability, price target, performance).